BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 15990804)

  • 1. Effects of montelukast in patients with persistent asthma using inhaled corticosteroids plus additional second-line therapy.
    Currie GP; Anderson WJ; Lee DK
    J Allergy Clin Immunol; 2005 Jul; 116(1):230. PubMed ID: 15990804
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-interventional study with remarkable results. Improved asthma control and quality of life with montelukast].
    MMW Fortschr Med; 2009 May; 151(21):40-1. PubMed ID: 19537636
    [No Abstract]   [Full Text] [Related]  

  • 4. Asthma and other wheezing disorders in infants and children.
    Keeley D; McKean M
    Clin Evid; 2004 Jun; (11):328-59. PubMed ID: 15652008
    [No Abstract]   [Full Text] [Related]  

  • 5. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
    Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR
    Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of leukotriene antagonists in asthma therapy raised].
    MMW Fortschr Med; 2008 Mar; 150(13):44-5. PubMed ID: 18522358
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
    Currie GP; Lee DK; Menzies D; Lipworth BJ
    Chest; 2006 Jul; 130(1):301-2. PubMed ID: 16840420
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
    Davies GM; Dasbach EJ; Santanello NC; Knorr BA; Bratton DL
    Clin Ther; 2004 Nov; 26(11):1895-904. PubMed ID: 15639701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukotriene antagonists].
    Mallet JP
    Allerg Immunol (Paris); 1999 Apr; 31(4):113-6. PubMed ID: 10370724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In patients with asthma that is not well controlled with inhaled steroids, does salmeterol (Serevent) or montelukast (Singulair) offer better symptom relief?
    Cash R; Blonski J
    J Fam Pract; 2001 Sep; 50(9):802. PubMed ID: 11674917
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with montelukast, a leukotriene receptor antagonist, in pediatric patients with asthma].
    Vega López M; Jiménez Ferral R
    Rev Alerg Mex; 2001; 48(5):133-6. PubMed ID: 11759254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
    Kopriva F; Dzubak P; Potesil J; Hajduch M
    J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast in guidelines and beyond.
    Bousquet J; Demoly P; Humbert M
    Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marginal utility of montelukast for persistent asthma.
    Mathison DA; Koziol JA
    Chest; 2002 Feb; 121(2):334-7. PubMed ID: 11834640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast for persistent asthma.
    Lipworth BJ; Fowler S; Currie G
    Lancet; 2001 Oct; 358(9291):1455; author reply 1456. PubMed ID: 11705517
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing compliance with inhaled corticosteroids through the use of combination therapy.
    Holt S; Masoli M; Beasley R
    J Allergy Clin Immunol; 2004 Feb; 113(2):219-20. PubMed ID: 14767433
    [No Abstract]   [Full Text] [Related]  

  • 18. Montelukast versus inhaled corticosteroids as monotherapy for prevention of asthma: which one is best?
    Miceli Sopo S; Onesimo R; Radzik D; Scala G; Cardinale F
    Allergol Immunopathol (Madr); 2009; 37(1):26-30. PubMed ID: 19268058
    [No Abstract]   [Full Text] [Related]  

  • 19. Asthma.
    Cates C; FitzGerald JM
    Clin Evid; 2002 Dec; (8):1506-29. PubMed ID: 12603951
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids].
    MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.